GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma

Clinical trial NCT07209813 · RECRUITING

Trial details

NCT number: NCT07209813
Sponsor: Beijing Gene Key Life Technology Co., Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Cancer

Start date: 2025-11-14
Primary completion: 2027-09-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.